Abstract
BACKGROUND: Indomethacin is the most frequently used pharmacological agent for closure of a patent ductus arteriosus (PDA) in premature infants. However, reports of complications, particularly, necrotizing enterocolitis (NEC) and isolated gastrointestinal perforation have generated concerns about the use of this medication.
OBJECTIVES: A retrospective study to compare the incidence of NEC, NEC-related gastrointestinal complications and isolated gastrointestinal perforation among premature infants treated for a PDA with either, indomethacin alone (I), surgical ligation alone (L), or indomethacin followed by surgical ligation (I–L).
METHODS: The medical records of 224 infants that underwent treatment, either pharmacological or surgical, for a PDA, confirmed by echocardiography, over a 4-year period (1995 to 1998) were analyzed. Treatment history and gastrointestinal complications were reviewed.
RESULTS: Of the 224 infants, 108 (48.2%) were treated with I, 50 (22.3%) by L, 66 (29.5%) with I–L. The clinical characteristics of the three treatment groups were similar and no differences in the incidence of NEC were observed between groups. NEC occurred in 14 (13%) of the I group, seven (14%) of the L group, and eight (12%) of the I–L group. The rate of NEC related gastrointestinal complications and isolated gastrointestinal perforation were also similar among groups.
CONCLUSION: In this large retrospective study, indomethacin treatment for a significant PDA in premature infants was not associated with a greater risk for NEC or NEC-related gastrointestinal complications than surgical ligation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Reller MD, Lorenz JM, Kotagal UR, Meyer RA, Kaplan S . Hemodynamically significant PDA: an echocardiographic and clinical assessment of incidence, natural history, and outcome in very low birth weight infants maintained in negative fluid balance. Pediatr Cardiol 1985;6:17–23.
Bai-Horng S, Ching-Tien P, Chang-Hai T . Echocardiographic flow pattern of patent ductus arteriosus: a guide to indomethacin treatment in premature infants. Arch Dis Child Fetal Neonatal Ed 1999;81:F197–F200.
Lemons JA, Bauer CR, Oh W, et al. Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 2001;107:E1.
Hack M, Friedman H, Fanaroff AA . Outcomes of extremely low birth weight infants. Pediatrics 1996;98:931–937.
Cotton RB, Stahlman MT, Kovar I, Catterton WZ . Medical management of small preterm infants with symptomatic patent ductus arteriosus. J Pediatr 1978;92:467–473.
Cassady G, Crouse DT, Kirklin JW, et al. A randomized, controlled trial of very early prophylactic ligation of the ductus arteriosus in babies who weighed 1000 g or less at birth. N Engl J Med 1989;320:1511–1516.
Marshall D, Kotelchuck M, Young TE, Bose CL, Kruyer L, O'Shea TM . Risk factors for chronic lung disease in the surfactant era: A North Carolina Population-based Study of Very Low Birth Weight Infants. Pediatrics 1999;104:1345–1350.
Brown ER . Increased risk of bronchopulmonary dysplasia in infants with patent ductus arteriosus. J Pediatr 1979;95:865–866.
Martin CG, Snider AR, Katz SM, Peabody JL, Brady JP . Abnormal cerebral blood flow patterns in preterm infants with a large patent ductus arteriosus. J Pediatr 1982;101:587–593.
Dudell GG, Gersony WM . Patent ductus arteriosus in neonates with severe respiratory disease. J Pediatr 1984;104:915–920.
Merritt TA, Harris JP, Roghmann K, et al. Early closure of the patent ductus arteriosus in very low-birth-weight infants: a controlled trial. J Pediatr 1981;99:281–286.
Grosfeld JL, Chaet M, Molinari F, et al. Increased risk of necrotizing enterocolitis in premature infants with patent ductus arteriosus treated with indomethacin. Ann Surg 1996;224:350–355.
Mavroudis C, Cook LN, Fleischaker JW, et al. Management of patent ductus arteriosus in the premature infant: indomethacin versus ligation. Ann Thorac Surg 1983;36:561–566.
Shorter NA, Liu JY, Mooney DP, Harmon BJ . Indomethacin-associated bowel perforations: a study of possible risk factors. J Pediatr Surg 1999;34:442–444.
Kumar RK, Yu VY . Prolonged low-dose indomethacin therapy for patent ductus arteriosus in very low birthweight infants. J Paediatr Child Health 1997;33:38–41.
Alpan G, Eyal F, Vinograd I, et al. Localized intestinal perforations after enteral administration of indomethacin in premature infants. J Pediatr 1985;106:277–281.
Kuhl G, Wille L, Bolkenius M, Seyberth HW . Intestinal perforation associated with indomethacin treatment in premature infants. Eur J Pediatr 1985;143:213–216.
Gordon P, Rutledge J, Sawin R, Thomas S, Woodrum D . Early postnatal dexamethasone increases the risk of focal small bowel perforation in extremely low birth weight infants. J Perinatol 1999;19:573–577.
Fujii AM, Brown E, Mirochnick M, O'Brien S, Kaufman G . Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus. J Perinatol 200;22:535–540.
Stark AR, Carlo WA, Tyson JE, et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. N Engl J Med 2001;344:95–101.
Coombs RC, Morgan ME, Durbin GM, Booth IW, McNeish AS . Gut blood flow velocities in the newborn: effects of patent ductus arteriosus and parenteral indomethacin. Arch Dis Child 1990;65:1067–1071.
Pezzati M, Vangi V, Biagiotti R, Bertini G, Cianciulli D, Rubaltelli FF . Effects of indomethacin and ibuprofen on mesenteric and renal blood flow in preterm infants with patent ductus arteriosus. J Pediatr 1999;135:733–738.
Fowlie PW, Davis PG . Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants. Cochrane Database Syst Rev 2002;(3):CD000174.
Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS . Effects of INDO in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr 1983;102:895–906.
Kliegman RM, Walsh MC . Neonatal necrotizing enterocolitis: pathogenesis, classification, and spectrum of illness. Curr Probl Pediatr 1987;17:213–288.
Papile LA, Burstein J, Burstein R, Koffler H . Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978;92:529–534.
Robie DK, Waltrip T, Garcia-Prats JA, Pokorny WJ, Jaksic T . Is surgical ligation of a patent ductus arteriosus the preferred initial approach for the neonate with extremely low birth weight? J Pediatr Surg 1996;31:1134–1137.
Koehne PS, Bein G, Alexi-Meskhishvili V, Weng Y, Buhrer C, Obladen M . Patent ductus arteriosus in very low birthweight infants: complications of pharmacological and surgical treatment. J Perinat Med 2001;29:327–334.
Tommiska V, Heinonen K, Ikonen S, et al. A national short-term follow-up study of extremely low birth weight infants born in Finland in 1996–97. Pediatrics 2001;107:E2.
Loh M, Osborn DA, Lui K . Outcome of very premature infants with necrotising enterocolitis cared for in centres with or without on site surgical facilities. Arch Dis Child Fetal Neonatal Ed 2001;85:F114–F118.
Acknowledgements
We thank Beth Lodinger, BSN, Suzanne Hegemier, BSN, Marcy Holden, BSN, Joan Wood, RN, and Audra Smith, for their participation in this study.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
O'Donovan, D., Baetiong, A., Adams, K. et al. Necrotizing Enterocolitis and Gastrointestinal Complications After Indomethacin Therapy and Surgical Ligation in Premature Infants With Patent Ductus Arteriosus. J Perinatol 23, 286–290 (2003). https://doi.org/10.1038/sj.jp.7210911
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jp.7210911
This article is cited by
-
The severity of NEC is ameliorated by prostaglandin E2 through regulating intestinal microcirculation
Scientific Reports (2023)
-
A quality improvement initiative to reduce necrotizing enterocolitis across hospital systems
Journal of Perinatology (2018)
-
Gastrointestinal complications associated with ibuprofen therapy for patent ductus arteriosus
Journal of Perinatology (2011)
-
Prenatal or postnatal indomethacin exposure and neonatal gut injury associated with isolated intestinal perforation and necrotizing enterocolitis
Journal of Perinatology (2010)
-
Association of Escherichia coli O157:H7 with necrotizing enterocolitis in a full-term infant
Pediatric Surgery International (2009)